Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC)
Clinical trial NCT02282371 · COMPLETED
Trial details
- NCT number
- NCT02282371
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-30
- Primary completion
- 2021-10-22
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.